Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC clinical trial (NCT06364917). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination treatment compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC clinical trial (NCT06364917). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC clinical trial (NCT06364917). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC clinical trial (NCT06364917). Contact the study team or your healthcare provider for specific answers.

Question 5

What will be monitored during the study, and how will my progress be assessed?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC clinical trial (NCT06364917). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC clinical trial (NCT06364917). Contact the study team or your healthcare provider for specific answers.

What this study is about